In the absence of SMAD4, the TGF-β signalling pathway-mediated downregulation of NLE1 is prevented by the ectopic expression of c-MYC, which occupies the E-box-containing region within the NLE1 promoter and upregulates NLE1, thereby promoting tumour progression [46]. The gene discussed is SMAD4; the disease is neoplasm.